Media Centre
Latest press releases
-
Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma
-
Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
-
Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn
-
Tagrisso approved in the EU for patients with unresectable EGFR-mutated lung cancer
-
Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
